Common Equity: The sum of all common equity items.
LAVA Therapeutics N.V. (LVTX) had Common Equity of $19.93M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-8.64M |
|
-- |
|
-- |
|
$7.29M |
|
$-7.29M |
|
$-1.28M |
|
$-8.57M |
|
$-8.57M |
|
$-8.64M |
|
$-8.64M |
|
$-8.64M |
|
$-8.64M |
|
$-7.29M |
|
$-7.83M |
|
26.90M |
|
26.90M |
|
$-0.32 |
|
$-0.32 |
|
| Balance Sheet Financials | |
$60.49M |
|
$0.04M |
|
$0.05M |
|
$60.55M |
|
$5.61M |
|
-- |
|
$35.00M |
|
$40.61M |
|
|
Common Equity |
$19.93M |
$19.93M |
|
$19.93M |
|
26.30M |
|
| Cash Flow Statement Financials | |
$-25.39M |
|
$12.66M |
|
-- |
|
$35.02M |
|
$26.38M |
|
$-8.63M |
|
$0.98M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.78 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-25.11M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-43.34% |
|
-43.34% |
|
-14.27% |
|
-43.34% |
|
$0.76 |
|
$-0.93 |
|
$-0.94 |
|